Donor Heart Preservation at 4-8°C Using Moderate Hypothermic Donor Heart Preservation Improves 4-year Survival in the US Guardian-Heart Registry
Document Type
Conference Proceeding
Publication Date
4-2025
Publication Title
Journal of Heart and Lung Transplantation
Abstract
Purpose: Static controlled hypothermic donor heart transportation (SCTS) is frequently used to preserve donor organs, utilized in almost 50% of US transplants in 2023. We now report follow-up through 4-years of post-transplant survival data comparing SCTS to historic transport using ice.
Methods: We analyzed the GUARDIAN-heart registry including 1,347 adults at 20 transplant centers in the US, comparing 4-year mortality rates between transplants utilizing the SCTS (N = 742) or conventional ice storage (N = 605). Propensity matching was conducted on variables of site, total ischemic time, donor age, baseline durable Left ventricular assist device (LVAD), and extracorporeal membrane oxygenation (ECMO).
Results: The SCTS cohort had significantly less severe primary graft dysfunction (PGD) and severe right ventricular dysfunction (RVD) compared to ice in the unmatched cohort, despite significantly longer ischemic times (Table). Following propensity matching to minimize potential confounders, SCTS had significantly lower severe PGD by 36% (p=0.035) and severe RVD by 44% (p=0.013). Survival was significantly greater through 4 years in SCTS (87% vs 85%, p=0.042, Figure), specifically due to significantly greater freedom from cardiovascular-related mortality (p=0.014). Further analysis with ongoing enrollment through January 2025 will be available for presentation.
Conclusion: Utilization of the SCTS for organ preservation is associated with significant improvements in post-transplant outcomes, including a statistically significant survival advantage through 4 years.
Volume
44
Issue
4 Suppl
First Page
s51
Last Page
s52
Recommended Citation
D'Alessandro D, Shudo Y, Rodrigo M, Pham S, Takeda K, Loyaga-Rendon R, et al. Donor heart preservation at 4-8°C using moderate hypothermic donor heart preservation improves 4-year survival in the US GUARDIAN-Heart Registry. J Heart Lung Transplant. 2025;44(4 Suppl):S51-S2. doi: 10.1016/j.healun.2025.02.108.
DOI
10.1016/j.healun.2025.02.108
ISSN
1053-2498
Comments
International Society for Heart and Lung Transplantation (ISHLT) 45th Annual Meeting, April 27-30, 2025, Boston, MA